Connect your AI

Vericel VCEL AFS Securities

AFS Securities at other companies

Globus MedicalGMED

——

Other financials

Income statement

Revenue$68.4M+30.1%

Gross profit$49.3M+35.8%

Operating income-$8.1M+37.0%

Net income-$6.3M+44.0%

EPS (diluted)-$0.12+47.8%

Balance sheet

Cash & equivalents$109.3M+37.1%

Total debt$95.0M-4.6%

Total equity$356.2M+20.6%

Total assets$485.6M+14.4%

Cash flow

Operating cash flow$16.4M+148%

CapEx$1.3M-91.2%

Free cash flow$15.1M+299%

Valuation

Market cap$2.13B-26.8%

Profitability

Gross margin74.8%+2.3pp

Operating margin5.4%+4.6pp

Net margin7.3%+6.1pp

FCF margin16.3%—

Returns & leverage

Return on equity6.6%+5.5pp

Debt / equity0.3×-0.1×

Current ratio5.2×+0.2×

Where this comes from

Reported directly by Vericel in its filing.

Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent.

The official record: Vericel’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vericel's afs securities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Vericel's AFS securities?: Vericel (VCEL) reported AFS securities of $65.28M in Q1 2026.
How has Vericel's AFS securities changed year-over-year?: Vericel's AFS securities increased by 50.6% year-over-year, from $43.34M to $65.28M.
What is the long-term trend for Vericel's AFS securities?: Over 5 years (2020 to 2025), Vericel's AFS securities has grown at a 20.6% compound annual growth rate (CAGR), from $24.1M to $61.4M.
What does AFS securities mean?: Debt securities classified as available-for-sale, measured at fair value with unrealized gains/losses in OCI rather than the income statement.